Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance

Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause of cancer related deaths in developed countries. Features such as dense stroma microenvironment, abnormal signaling pathways, and genetic heterogeneity of the tumors contribute to its chemoresistant character...

Full description

Bibliographic Details
Main Authors: Ntombikayise Xelwa, Geoffrey Patrick Candy, John Devar, Jones Omoshoro-Jones, Martin Smith, Ekene Emmanuel Nweke
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.683788/full
_version_ 1830429904147054592
author Ntombikayise Xelwa
Geoffrey Patrick Candy
John Devar
Jones Omoshoro-Jones
Martin Smith
Ekene Emmanuel Nweke
author_facet Ntombikayise Xelwa
Geoffrey Patrick Candy
John Devar
Jones Omoshoro-Jones
Martin Smith
Ekene Emmanuel Nweke
author_sort Ntombikayise Xelwa
collection DOAJ
description Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause of cancer related deaths in developed countries. Features such as dense stroma microenvironment, abnormal signaling pathways, and genetic heterogeneity of the tumors contribute to its chemoresistant characteristics. Amongst these features, growth factors have been observed to play crucial roles in cancer cell survival, progression, and chemoresistance. Here we review the role of the individual growth factors in pancreatic cancer chemoresistance. Importantly, the interplay between the tumor microenvironment and chemoresistance is explored in the context of pivotal role played by growth factors. We further describe current and future potential therapeutic targeting of these factors.
first_indexed 2024-12-21T01:41:34Z
format Article
id doaj.art-c3a05274f9954a05b10e9e73e50e4db4
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-21T01:41:34Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c3a05274f9954a05b10e9e73e50e4db42022-12-21T19:20:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.683788683788Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting ChemoresistanceNtombikayise XelwaGeoffrey Patrick CandyJohn DevarJones Omoshoro-JonesMartin SmithEkene Emmanuel NwekePancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause of cancer related deaths in developed countries. Features such as dense stroma microenvironment, abnormal signaling pathways, and genetic heterogeneity of the tumors contribute to its chemoresistant characteristics. Amongst these features, growth factors have been observed to play crucial roles in cancer cell survival, progression, and chemoresistance. Here we review the role of the individual growth factors in pancreatic cancer chemoresistance. Importantly, the interplay between the tumor microenvironment and chemoresistance is explored in the context of pivotal role played by growth factors. We further describe current and future potential therapeutic targeting of these factors.https://www.frontiersin.org/articles/10.3389/fonc.2021.683788/fullpancreatic cancerchemoresistancegrowth factorschemotherapysignaling pathways
spellingShingle Ntombikayise Xelwa
Geoffrey Patrick Candy
John Devar
Jones Omoshoro-Jones
Martin Smith
Ekene Emmanuel Nweke
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
Frontiers in Oncology
pancreatic cancer
chemoresistance
growth factors
chemotherapy
signaling pathways
title Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
title_full Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
title_fullStr Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
title_full_unstemmed Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
title_short Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
title_sort targeting growth factor signaling pathways in pancreatic cancer towards inhibiting chemoresistance
topic pancreatic cancer
chemoresistance
growth factors
chemotherapy
signaling pathways
url https://www.frontiersin.org/articles/10.3389/fonc.2021.683788/full
work_keys_str_mv AT ntombikayisexelwa targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance
AT geoffreypatrickcandy targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance
AT johndevar targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance
AT jonesomoshorojones targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance
AT martinsmith targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance
AT ekeneemmanuelnweke targetinggrowthfactorsignalingpathwaysinpancreaticcancertowardsinhibitingchemoresistance